Fagron NV signed an agreement to acquire Parma Produkt Gyógyszergyártó Korlátolt Felelosségu Társaság.
close early January 2024.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
18.74 EUR | 0.00% | +2.52% | +12.82% |
04-11 | Transcript : Fagron NV, Q1 2024 Sales/ Trading Statement Call, Apr 11, 2024 | |
04-11 | Fagron Reports Revenue Results for the First Quarter Ended 31 March 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
+12.82% | 1.47B | |
+32.95% | 698B | |
+26.51% | 568B | |
-4.97% | 358B | |
+18.83% | 328B | |
+3.54% | 283B | |
+15.96% | 238B | |
+6.68% | 203B | |
-9.08% | 198B | |
+6.70% | 165B |